Visit COVID-19 resources

[Skip to Content]

consultation

RCOphth Cataract Workforce Guidance Consultation Open Now

This consultation seeks views on the proposed RCOphth Cataract Workforce Guidance. The cataract workforce group was set up to quantify the demand for cataract surgery over the next 10 years and define the workforce required to meet this demand in a sustainable way in response to increasing vacancies for eye consultants in the UK in

NICE serious eye disorders quality standard consultation

The NICE serious eye disorders quality standard consultation will run from 10/09/2018 to 08/10/2018. Registered stakeholders will be notified on the day the consultation opens with instructions on how to submit comments. For further information on the quality standard or the NICE quality standards programme in general please see the links below. Serious eye disorders

The Royal College of Ophthalmologists responds to the HEE Workforce consultation

Health Education England (HEE), the body responsible for overseeing training of the NHS workforce, has begun developing its first ever system-wide strategy for delivering the NHS and social care workforce for the next two decades. They published a first draft of the strategy for consultation which we and other health and care organisations responded to.

Government consultation on opt-out system for organ and tissue donation

The Government has launched a consultation on a proposal to change the consent for organ and tissue donation to an ‘opt out system’. Although 8 out of 10 people say they would want to donate their organs and tissue after their death, most people never register to be organ donors. The Royal College of Ophthalmologists

NICE issue consultation on draft guideline on macular degeneration

The National Institute for Health and Care Excellence has opened a consultation for their draft guideline on macular degeneration, closing 24 August 2017 at 17:00. The draft guideline provides advice on the management of people with AMD, including pharmacological and non-pharmacological treatments. It also provides guidance on tools available to diagnose and monitor AMD, and what information and support